The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
A regulatory system for use in gene transfer.
Open accessAbstract
We recently have demonstrated that a C-terminal deletion mutant of the human progesterone receptor (hPRB891) fails to bind to progesterone but can bind RU 486 (Mifepristone) and other progesterone antagonists. Most significantly, this mutant receptor activates transcription of a reporter gene containing the progesterone response element in the presence of these antagonists. Taking advantage of this finding and the modular nature of functional domains of steroid receptors, we constructed a chimeric regulator (pGL-VP) by fusing the ligand-binding domain of human progesterone receptor hPRB891 to the yeast transcriptional activator GAL4 DNA-binding domain and the herpes simplex virus protein VP16 activation domain. We demonstrated that this chimeric regulator activates target genes containing the GAL4-binding sites in transient transfection assays in response to RU 486. In addition, this regulatory system has been validated by ex vivo transplantation of a stable cell line containing both the regulator and a reporter gene into rats. The dosage of RU 486 used is significantly lower than that required for antagonizing progesterone action. The gene-switch system reported here represents a regulatory system, which could be applicable for gene-transfer studies involving animals, as well as humans, in which the delivered gene(s) can be specifically turned on/off in response to an exogenous compound.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,439
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943
Current Protocols in Molecular Biology
Teplitz, R. (1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03420090114049 · Cited by 1,803
GAL4-VP16 is an unusually potent transcriptional activator
Sadowski, I., Ma, J., Triezenberg, S., & Ptashne, M. (1988) · Nature · doi:10.1038/335563a0 · Cited by 1,333
Controlling Signal Transduction with Synthetic Ligands
Spencer, D. M., Wandless, T. J., Schreiber, S. L., & Crabtree, G. R. (1993) · Science · doi:10.1126/science.7694365 · Cited by 843
Transcription activation by the adenovirus E1a protein
Lillie, J. W., & Green, M. R. (1989) · Nature · doi:10.1038/338039a0 · Cited by 632
Keegan, L., Gill, G., & Ptashne, M. (1986) · Science · doi:10.1126/science.3080805 · Cited by 612
MINIREVIEW: The Steroid Receptor Superfamily: More Excitement Predicted for the Future
O'Malley, B. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-3-363 · Cited by 485
Self-citationContragestion and Other Clinical Applications of RU 486, an Antiprogesterone at the Receptor
Baulieu, E.-E. (1989) · Science · doi:10.1126/science.2781282 · Cited by 483
Lee, F., Mulligan, R., Berg, P., & Ringold, G. (1981) · Nature · doi:10.1038/294228a0 · Cited by 466
Picard, D., Salser, S. J., & Yamamoto, K. R. (1988) · Cell · doi:10.1016/0092-8674(88)90122-5 · Cited by 410
Goodrich, J. A., Hoey, T., Thut, C. J., Admon, A., & Tjian, R. (1993) · Cell · doi:10.1016/0092-8674(93)90386-5 · Cited by 405
Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone
Grunberg, S. M., Weiss, M. H., Spitz, I. M., Ahmadi, J., Sadun, A., Russell, C. A., Lucci, L., & Stevenson, L. L. (1991) · Journal of Neurosurgery · doi:10.3171/jns.1991.74.6.0861 · Cited by 379
Vegeto, E., Allan, G. F., Schrader, W. T., Tsai, M.-J., McDonnell, D. P., & O'Malley, B. W. (1992) · Cell · doi:10.1016/0092-8674(92)90234-4 · Cited by 377
Self-citationBinding of general transcription factor TFIIB to an acidic activating region
Lin, Y.-S., Ha, I., Maldonado, E., Reinberg, D., & Green, M. R. (1991) · Nature · doi:10.1038/353569a0 · Cited by 366
Reduced binding of TFIID to transcriptionally compromised mutants of VP16
Ingles, C. J., Shales, M., Cress, W. D., Triezenberg, S. J., & Greenblatt, J. (1991) · Nature · doi:10.1038/351588a0 · Cited by 327
The Antiprogestin Steroid RU 486 and Human Fertility Control
(1985) · Springer eBooks · doi:10.1007/978-1-4684-1242-0 · Cited by 298
Baniahmad, A., Köhne, A. C., & Renkawitz, R. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05140.x · Cited by 291
An amino-terminal fragment of GAL4 binds DNA as a dimer
Carey, M., Kakidani, H., Leatherwood, J., Mostashari, F., & Ptashne, M. (1989) · Journal of Molecular Biology · doi:10.1016/0022-2836(89)90007-7 · Cited by 281
Mayo, K. E., Warren, R., & Palmiter, R. D. (1982) · Cell · doi:10.1016/0092-8674(82)90094-0 · Cited by 253
Mifepristone (RU 486) -- A Modulator of Progestin and Glucocorticoid Action
Wood, A. J. J., Spitz, I. M., & Bardin, C. W. (1993) · New England Journal of Medicine · doi:10.1056/nejm199308053290607 · Cited by 221
Identification of a Dominant Negative Form of the Human Estrogen Receptor
Wang, Y., & Miksicek, R. J. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-11-1707 · Cited by 207
Self-citationParkinson's disease: from brain homogenate to treatment.
Hornykiewicz, O. (1973) · PubMed · Cited by 178
Braselmann, S., Graninger, P., & Busslinger, M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1657 · Cited by 173
Context affects nuclear protein localization in Saccharomyces cerevisiae.
Nelson, M. K., & Silver, P. A. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.2.384 · Cited by 123
Swahn, M. L., Bygdeman, M., Cekan, S. Z., Xing, S., Masironi, B., & JOHANNISSON, E. (1990) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a137111 · Cited by 106
Baim, S. B., Labow, M., Levine, A. J., & Shenk, T. E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5072 · Cited by 98
Brogden, R. N., Goa, K. L., & Faulds, D. M. (1993) · Drugs · doi:10.2165/00003495-199345030-00007 · Cited by 87
Cited by
Subregion- and Cell Type–Restricted Gene Knockout in Mouse Brain
Tsien, J. Z., Chen, D. F., Gerber, D., Tom, C., Mercer, E. H., Anderson, D. J., Mayford, M., Kandel, E. R., & Tonegawa, S. (1996) · Cell · doi:10.1016/s0092-8674(00)81826-7 · Cited by 1,280
Genetic Dissection of Neural Circuits
Luo, L., Callaway, E. M., & Svoboda, K. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.002 · Cited by 756
REGULATION OF PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP) GENE EXPRESSION
Hanson, R. W., & Reshef, L. (1997) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.66.1.581 · Cited by 729
Design and Selection of Novel Cys2His2 Zinc Finger Proteins
Pabo, C. O., Peisach, E., & Grant, R. A. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.313 · Cited by 715
GENE THERAPY: Twenty-First Century Medicine
Verma, I. M., & Weitzman, M. D. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.050304.091637 · Cited by 616
Metadata
- Authors
- Wang, Y., O'Malley, B. W., Tsai, S. Y., & O'Malley, B. W.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1994-08-16
- Volume
- 91
- Issue
- 17
- Pages
- 8180-8184
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2007095985
- Cited by
- 431
- References
- 28
- FWCI
- 9.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.